We keep telling them, but some critics still doubt that Direct Care can save patients a tremendous amount of money each month.
Venlafaxine tablets (generic for Effexor) is a prime example.
Assuming you know about the coupon option, you can buy the generic for $17. However, if not, you’ll pay ~$150 cash.
Keep in mind that we can sell a monthly script of Venlafaxine tablets for $5.70.
And, if your doc writes the Rx for the capsule instead of the tablet, then it’s $118 cash or about $50 with a coupon.
Sure, it might be an innocent mistake, but this is all a bit ridiculous, right?
According to representatives of Goodrx:
- 40% of their offerings are lower than a 10$ copay
- 80% of their offerings are lower than 20$ copays
What does this mean? If you’re paying for full coverage and paying copays that are higher than $20, you have savings potential through our Direct Care model.
However, the fight for lower prices in healthcare is not a priority for policy makers or insurance companies. It’s not in their psychology. Especially when the population at large is left to assume their must be a “benefit” to those $50 capsules. Something “extra” that makes them more valuable.
I’m telling you that whatever that “benefit” is, you don’t need it. And you shouldn’t be pressured into expensive, comprehensive insurance just to bring the cost down for a prescription that costs pennies.
I can sell you a much cheaper placebo. In fact, I could give you sugar pills free of charge.